Stay updated on ALXN1210 vs Eculizumab in PNH Clinical Trial
Sign up to get notified when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.

Latest updates to the ALXN1210 vs Eculizumab in PNH Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study page now shows Revision: v3.6.3, replacing the previous v3.6.0. This indicates a newer page revision without changes to the study data or eligibility criteria.SummaryDifference0.0%

- Check34 days agoChange DetectedRecruitment status now indicates the study is not enrolling. New guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) are added, the Intervention/Treatment label formatting is updated, and the page revision is noted as v3.6.0.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows a new revision label (v3.5.5) replacing the previous v3.5.4, indicating a minor site update.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous revision label v3.5.3, indicating a new version of the page or its underlying platform.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page’s UI/release revision label was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version bump without changing the study record content.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to ALXN1210 vs Eculizumab in PNH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.